Search results: “SARS-CoV”
Showing 1–50 of 160 results
Mouse Anti SARS-CoV-2 Spike (S1) RBD Antibody (CE5)
Mouse anti SARS-CoV-2 spike (S1) RBD antibody (CE5) is a monoclonal antibody that is specific for the spike receptor binding domain of SARS-CoV-2, recognizing both Wuhan-Hu-1 and the Indian (Delta) variant. No cross-reactivity observed in ELISA using RBD from SARS-CoV-2 UK (Alpha), South African (Beta) or Brazilian (Gamma) variants, or SARS-CoV-2 spike subunit 2 (S2) or spike subunit 1 (S1) proteins from SARS-CoV, MERS-CoV, HCoV-NL63, HCoV-OC43, HCoV-229E and HCoV-HKU1. It does not bind to SARS-CoV-2 (D614G, E484K Mutant) S1 (REC31902). This antibody has been manufactured for use in ELISA immunoassay development and is suitable for use as a capture or detection antibody in ELISA assays.
SARS-CoV-2 Spike N-Terminal Domain (NTD), His-Tag (HEK293)
Recombinant SARS-CoV-2 Spike protein N-terminal domain (NTD). This domain shows the lowest sequence ID compared to SARS-CoV Spike protein. The protein is produced in HEK293 cells and purified from culture supernatant by affinity chromatography. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Mouse Anti SARS-CoV-2 Spike (S1) Antibody (HH10)
Mouse anti SARS-CoV-2 spike (S1) antibody (HH10) is a monoclonal antibody that is specific for the spike subunit 1 (S1) of SARS-CoV-2, the causative agent of COVID-19. Antibody also binds to SARS-CoV-2 mutant spike proteins REC31899 (D614G, S477N), REC31900 (D614G, L84I, N439K), REC31901 (D614G, G485R), REC31902 (D614G, E484K) and REC31903 (D614G, V445I, H655Y, E583D), and N-terminal domain (NTD, REC31835). Antibody does not cross-react in ELISA with SARS-CoV-2 RBD (Wuhan-Hu-1, UK, Brazilian, Indian Kerala, South African variants), SARS-CoV-2 spike subunit 2 (S2) or spike proteins from SARS-CoV, MERS-CoV, HCoV-NL63, HCoV-OC43, HCoV-229E and HCoV-HKU1. This antibody has been manufactured for use in ELISA immunoassay development.
Mouse Anti SARS-CoV-2 Spike (S1) Antibody (FH4)
Mouse anti SARS-CoV-2 spike (S1) antibody (FH4) is a monoclonal antibody that is specific for the spike subunit 1 (S1) of SARS-CoV-2, the causative agent of COVID-19. Antibody also binds to SARS-CoV-2 mutant spike proteins REC31899 (D614G, S477N), REC31900 (D614G, L84I, N439K), REC31901 (D614G, G485R), REC31902 (D614G, E484K) and REC31903 (D614G, V445I, H655Y, E583D), and N-terminal domain (NTD, REC31835). Antibody does not cross-react in ELISA with SARS-CoV-2 RBD (Wuhan-Hu-1, UK, Brazilian, Indian, South African variants), SARS-CoV-2 spike subunit 2 (S2) or spike proteins from SARS-CoV, MERS-CoV, HCoV-NL63, HCoV-OC43, HCoV-229E and HCoV-HKU1. This antibody has been manufactured for use in ELISA immunoassay development and is suitable for use as a capture or detection antibody in ELISA assays.
SARS-CoV-2 Spike Glycoprotein (Trimeric), His-Tag (CHO)
SARS-CoV-2 trimeric spike glycoprotein is manufactured in CHO cells to high yield and purity. Protein has proline substitutions at residues 986 and 987, a GSAS substitution at the furin cleavage site (residues 682–685), and a C-terminal His-tag. HRP conjugated protein also available. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 Spike N-Terminal Domain (NTD), Sheep Fc-Tag (HEK293)
Recombinant SARS-CoV-2 Spike protein N-terminal domain (NTD) is manufactured in HEK293 cells and purified to greater than 95% purity from culture supernatant with a sheep Fc-tag. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Mouse Anti SARS-CoV-2 Spike (S1) RBD Antibody (DH6)
Mouse anti SARS-CoV-2 spike (S1) RBD antibody (DH6) is a monoclonal antibody that is specific for the spike receptor binding domain of SARS-CoV-2, recognizing RBD from Wuhan-Hu-1, UK (Alpha), South African (Beta) Brazilian (Gamma) and Indian Kerala variants. No cross-reactivity observed in ELISA with SARS-CoV-2 subunit 2 (S2) or spike subunit 1 (S1) proteins from SARS-CoV, MERS-CoV, HCoV-NL63, HCoV-OC43, HCoV-229E and HCoV-HKU1. This antibody has been manufactured for use in ELISA immunoassay development and can be used as a capture or detection antibody in ELISA assays. HRP-conjugated antibody also available. Antibody is neutralizing against SARS-CoV-2, but not against SARS-CoV-1 or MERS-CoV.
SARS-CoV-2 Spike Glycoprotein (Full-Length), His-Tag (CHO)
Recombinant full-length SARS-CoV-2 spike glycoprotein, manufactured in Chinese hamster ovary (CHO) cells to high yield and purity. The furin cleavage site (amino acids 682-685) has been mutated from RRAR to SRAS and the transmembrane domain and intravirion part replaced with a glycine-serine linker and a His-tag. Horseradish peroxidase conjugated protein also available. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Mouse Anti SARS-CoV-2 Spike (S1) Antibody (EB5)
Mouse anti SARS-CoV-2 spike (S1) antibody (EB5) is a monoclonal antibody that is specific for the spike subunit 1 (S1) of SARS-CoV-2, the causative agent of COVID-19. Antibody also binds to mutant spike proteins REC31899 (D614G, S477N), REC31900 (D614G, L84I, N439K), REC31901 (D614G, G485R), REC31902 (D614G, E484K) and REC31903 (D614G, V445I, H655Y, E583D), and N-terminal domain (NTD, REC31835). Antibody does not cross-react in ELISA with SARS-CoV-2 RBD (Wuhan-Hu-1, UK, Brazilian, Indian, South African variants), SARS-CoV-2 spike subunit 2 (S2) or spike proteins from SARS-CoV, MERS-CoV, HCoV-NL63, HCoV-OC43, HCoV-229E and HCoV-HKU1. This antibody has been manufactured for use in ELISA immunoassay development; HRP conjugated antibody is also available.
SARS-CoV-2 Spike Glycoprotein (S1) RBD, His-Tag (HEK293)
SARS-CoV-2 Spike S1 RBD is a recombinant receptor-binding domain antigen, expressed in HEK293 cells and purified from culture supernatant with a His-tag to These proteins can be used as diagnostic standard antigens, targets of neutralizing antibodies and in the development of antibodies to detect SARS-CoV-2 in patients.
Mouse Anti SARS-CoV-2 Spike (S1) RBD Antibody (FG11)
Mouse anti SARS-CoV-2 spike (S1) RBD antibody (FG11) is a monoclonal antibody that is specific for the spike receptor binding domain of SARS-CoV and SARS-CoV-2, recognizing RBD from Wuhan-Hu-1, UK (Alpha), South African (Beta) Brazilian (Gamma) and Indian variants. No cross-reactivity observed in ELISA with SARS-CoV-2 subunit 2 (S2) or spike subunit 1 (S1) proteins from MERS-CoV, HCoV-NL63, HCoV-OC43, HCoV-229E and HCoV-HKU1. This antibody has been manufactured for use in ELISA immunoassay development.
Mouse Anti SARS-CoV-2 Spike (S2) Antibody (JC7)
Mouse anti SARS-CoV-2 Spike (S2) antibody (JC7) is a monoclonal antibody that recognizes the Spike subunit 2 (S2) glycoprotein of SARS-CoV-2, which is the causative agent of COVID-19. This antibody has been manufactured for use in ELISA immunoassay development.
Mouse Anti SARS-CoV-2 Spike (S2) Antibody (HA11)
Mouse anti SARS-CoV-2 Spike (S2) antibody (HA11) is a monoclonal antibody that recognizes the Spike subunit 2 (S2) glycoprotein of SARS-CoV-2, which is the causative agent of COVID-19. This antibody has been manufactured for use in ELISA immunoassay development.
Mouse Anti SARS-CoV-2 Spike (S2) Antibody (CH1)
Mouse anti SARS-CoV-2 Spike (S2) antibody (CH1) is a monoclonal antibody that recognizes the Spike subunit 2 (S2) glycoprotein of SARS-CoV-2, which is the causative agent of COVID-19. This antibody has been manufactured for use in ELISA immunoassay development.
Mouse Anti SARS-CoV-2 Spike (S2) Antibody (AD10)
Mouse anti SARS-CoV-2 Spike (S2) antibody (AD10) is a monoclonal antibody that recognizes the Spike subunit 2 (S2) glycoprotein of SARS-CoV-2, which is the causative agent of COVID-19. This antibody has been manufactured for use in ELISA immunoassay development and is suitable for use as a capture antibody in ELISA assays. HRP and Biotin conjugated antibody also available.
SARS-CoV-2 Spike Glycoprotein (S2), His-Tag (Insect Cells)
SARS-CoV-2 Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike protein amino acids 685-1211 of subunit 2. Spike S2 protein is manufactured to high yield and purity using the Native Antigens baculovirus-insect cell platform. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 Spike Glycoprotein (S1), His-Tag (Insect Cells)
SARS-CoV-2 (formerly known as Novel Coronavirus 2019-nCoV) Spike Glycoprotein (S1) is a recombinant antigen which contains the Spike protein amino acids 1-674 of subunit 1. Spike S1 protein is manufactured to high yield and purity using the Native Antigens baculovirus-insect cell platform. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Human IgM Anti SARS-CoV-2 Spike (S2) Antibody (AD10)
Recombinant humanized IgM version of the mouse monoclonal antibody MAB12446. Antibody is specific for SARS-CoV-2 spike subunit 2 (S2).
Human IgM Anti SARS-CoV-2 Spike (S2) Antibody (CH1)
Recombinant humanized IgM version of the mouse monoclonal antibody MAB12447. Antibody is specific for SARS-CoV-2 spike subunit 2 (S2).
Human IgG1 Anti SARS-CoV-2 Spike (S2) Antibody (CH1)
Recombinant humanized version of the mouse monoclonal antibody MAB12447. Antibody is specific for SARS-CoV-2 spike subunit 2 (S2). This antibody has been manufactured for use in ELISA immunoassay development.
SARS-CoV-2 Spike Glycoprotein (S2), Sheep Fc-Tag (HEK293)
SARS-CoV-2 (formerly known as Novel Coronavirus 2019-nCoV) Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike subunit 2 protein, amino acids 685-1211. Spike S2 protein is manufactured in HEK293 mammalian cells to obtain more authentic post-translational modifications, compared to other expression systems. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease. Horseradish peroxidase (HRP) conjugated protein is also available ready for use in various immunochemical assays including Western blotting, immunohistochemistry, ELISA applications and double‐antigen bridging assays (DABA).
SARS-CoV-2 Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293)
SARS-CoV-2 (formerly known as Novel Coronavirus 2019-nCoV) Spike Glycoprotein (S1) is a recombinant antigen which contains amino acids 1-674 of subunit 1. Spike S1 protein is manufactured in HEK293 mammalian cells to obtain more authentic post-translational modifications, compared to other expression systems. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease. Horseradish peroxidase (HRP) conjugated protein is also available ready for use in various immunochemical assays including Western blotting, immunohistochemistry, ELISA applications and double‐antigen bridging assays (DABA).
SARS-CoV-2 Spike Glycoprotein (S2), Sheep Fc-Tag (CHO)
SARS-CoV-2 (formerly known as Novel Coronavirus 2019-nCoV) Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike subunit 2 protein, amino acids 685-1211. Spike S2 protein is manufactured in CHO mammalian cells to SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 Spike Glycoprotein (S1), Sheep Fc-Tag (CHO)
SARS-CoV-2 (formerly known as Novel Coronavirus 2019-nCoV) Spike Glycoprotein (S1) is a recombinant antigen which contains amino acids 1-674 of subunit 1. Spike S1 protein is manufactured in CHO mammalian cells to SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Human IgM Anti SARS-CoV-2 Spike (S1) RBD Antibody (DH6)
Recombinant humanized version of the neutralizing mouse monoclonal antibody MAB12444. Antibody is specific for SARS-CoV-2 receptor binding domain (RBD). The original monoclonal antibody (MAB12444) is neutralizing against SARS-CoV-2, but not against SARS-CoV-1 or MERS-CoV.
Human IgG1 Anti SARS-CoV-2 Spike (S1) RBD Antibody (DH6)
Recombinant humanized version of the neutralizing mouse monoclonal antibody MAB12444. Antibody is specific for SARS-CoV-2 receptor binding domain (RBD). The original monoclonal antibody (MAB12444) is neutralizing against SARS-CoV-2, but not against SARS-CoV-1 or MERS-CoV. This antibody has been manufactured for use in ELISA immunoassay development.
Human IgG1 Anti SARS-CoV-2 Spike (S1) RBD Antibody (CE5)
Recombinant humanized version of the neutralizing mouse monoclonal antibody MAB12443. Antibody is specific for SARS-CoV-2 receptor binding domain (RBD). This antibody has been manufactured for use in ELISA immunoassay development.
Mouse Anti SARS-CoV-2 Nucleoprotein Antibody (JF1)
Mouse anti SARS-CoV-2 nucleoprotein antibody recognizes the nucleocapsid protein of SARS-CoV-2 (COVID-19) in ELISA. Antibody does not cross-react with SARS-CoV, HCoV-229E, HCoV-HKU1, HCoV-NL63 and HCoV-OC43. Antibody can be used as a capture antibody in sandwich ELISA, with MAB12465 or MAB12467 as detection antibodies. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.1.28) Spike Glycoprotein (S1) RBD, His-Tag (HEK293)
BRAZILIAN (GAMMA) VARIANT SARS-CoV-2 spike receptor binding domain (RBD) from Brazilian variant. Contains amino acid changes K417T, E484K, N501Y relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.1.7) Spike Glycoprotein (Full-Length), His-Tag (HEK293)
UNITED KINGDOM (ALPHA) VARIANT SARS-CoV-2 Spike protein that contains all amino acid changes of the “UK variant” B.1.1.7 of SARS-CoV-2: 69-70del, Y144del, N501Y, A570D, P681H, T716I, S982A, D1118H relative to Wuhan-Hu-1. This construct has a functional furin cleavage site. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 Spike Glycoprotein (S2) (aa 1000-1200), His-Tag (E. coli)
SARS-CoV-2 Spike Glycoprotein (S2) is a recombinant antigen manufactured in E. coli and containing the Spike subunit 2 immunodominant region (amino acids 1000 to 1200). SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 Spike Glycoprotein (S2) (aa 800-1000), His-Tag (E. coli)
SARS-CoV-2 Spike Glycoprotein (S2) is a recombinant antigen manufactured in E. coli and containing the Spike subunit 2 immunodominant region (amino acids 800 to 1000). SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 Spike-E-M Mosaic Protein, His-Tag (E. coli)
SARS-CoV-2 Spike-E-M Mosaic protein is a recombinant antigen manufactured in E. coli with greater than 95% purity, and containing the Spike (S), Envelope (E) and Membrane (M) immunodominant regions. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Rabbit IgG Anti SARS-CoV-2 Spike (S1) RBD Polyclonal Antibody
Rabbit anti SARS-CoV-2 (Covid-19) spike receptor binding domain (RBD) antibody, for use in ELISA and Western blot applications. Antibody recognizes RBD from Wuhan-Hu-1, UK (Alpha), South African (Beta) Brazilian (Gamma) and Indian variants. Antibody does not cross-react in ELISA with HCoV-229E full-length spike protein (REC31880). SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.1.7 + E484K) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293)
UNITED KINGDOM (ALPHA) VARIANT Pre-fusion stabilized SARS-CoV-2 Spike protein of the 'New Kent'; variant B.1.1.7 containing amino acid change E484K (in addition to 69-70del, Y144del, N501Y, A570D, P681H, T716I, S982A, D1118H). SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease. Lineage B.1.1.7 (Variant of Concern 202012/01) is correlated with a significant increase in the rate of COVID-19 infection in the UK.
Mouse Anti SARS-CoV-2 Nucleoprotein Antibody (GC12)
Anti SARS-CoV-2 nucleoprotein antibody recognizes the nucleocapsid protein of SARS-CoV-2 (COVID-19) and SARS-CoV in ELISA and does not cross-react with HCoV-229E, HCoV-HKU1, HCoV-NL63 and HCoV-OC43. Antibody can be used as a detection antibody in sandwich ELISA, with MAB12468 as a capture antibody. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.617.2; AY.1, AY.2, AY.3) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293)
INDIAN (DELTA) VARIANT SARS-CoV-2 (B.1.617.2; AY.1, AY.2, AY.3) stabilized Spike from the Indian (Delta) variant. Contains T19R, T95I, G142D, E156G, del157-158, W258L, N417K, L452R, T478K, D614G, P681R, D950N mutations. The protein was produced in HEK293 cells and purified from culture supernatant. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.617.2) Spike Glycoprotein (S1) RBD, His-Tag (HEK293)
INDIAN (DELTA) VARIANT SARS-CoV-2 (B.1.617.2) RBD mutant from the Delta variant. Contains amino acid changes L452R, T478K relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (N501Y Mutant) Spike Glycoprotein (S1) RBD, His-Tag (HEK293)
UNITED KINGDOM (ALPHA) VARIANT SARS-CoV-2 (N501Y mutant) spike subunit 1 (S1) receptor binding domain (RBD) is a recombinant antigen manufactured in HEK293 cells to high purity. This antigen contains N501Y amino acid change relative to the Wuhan-Hu-1 isolate. The N501Y mutation has been reported to increase binding affinity to human ACE2. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.1.7) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293)
UNITED KINGDOM (ALPHA) VARIANT SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease. Lineage B.1.1.7 (Variant of Concern 202012/01) is correlated with a significant increase in the rate of COVID-19 infection in the UK and includes amino acid substitutions 69-70del, Y144del, N501Y, A570D, P681H, T716I, S982A, D1118H relative to the prototypic Wuhan-Hu-1 strain.
Mouse Anti SARS-CoV-2 Nucleoprotein Antibody (JB8)
Mouse anti SARS-CoV-2 nucleoprotein antibody recognizes the nucleocapsid protein of SARS-CoV-2 (COVID-19) and SARS-CoV in ELISA. Antibody does not cross-react with HCoV-229E, HCoV-HKU1, HCoV-NL63 and HCoV-OC43. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293)
SARS-CoV-2 Stabilized Spike (full-length) is a recombinant antigen which contains 6 mutations in S2 which stabilises the protein as a pre-fusion trimer. The protein was produced according to Hsieh et al. in HEK293 cells and purified from culture supernatant by affinity chromatography. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Mouse Anti SARS-CoV-2 Nucleoprotein Antibody (JA6)
Mouse anti SARS-CoV-2 nucleoprotein antibody recognizes the nucleocapsid protein of SARS-CoV-2 (COVID-19) in ELISA. Antibody does not cross-react with HCoV-229E, HCoV-HKU1, HCoV-NL63 and HCoV-OC43. Antibody can be used as a detection antibody in sandwich ELISA, with MAB12468 as a capture antibody. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.351/501Y.V2) Spike Glycoprotein (S1) RBD, His-Tag (HEK293)
SOUTH AFRICAN (BETA) VARIANT SARS-CoV-2 spike receptor binding domain (RBD) from South African variant. Contains amino acid changes K417N, E484K, N501Y relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (HH10)
Recombinant humanized version of the mouse monoclonal antibody MAB12442. Antibody is specific for SARS-CoV-2 spike subunit 1 protein. This antibody has been manufactured for use in ELISA immunoassay development.
SARS-CoV-2 (B.1.351) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293)
SOUTH AFRICAN (BETA) VARIANT SARS-CoV-2 (B.1.351) stabilized spike glycoprotein, from the South Africa variant. It contains amino acid changes L18F, D80A, D215G, del242-244, K417N, E484K, N501Y, D614G, and A701V, relative to Wuhan-Hu-1. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.1.28/P.1) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293)
BRAZILIAN (GAMMA) VARIANT Pre-fusion stabilized SARS-CoV-2 Spike protein of the virus variant B.1.1.28/P1 (Brazilian variant) containing amino acid changes L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, V1176F relative to Wuhan Hu-1. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.351/501.V2) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293)
SOUTH AFRICAN (BETA) VARIANT SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease. The B.1.351/501.V2 variant, also known as 501.V2, 20H/501Y.V2 (formerly 20C/501Y.V2), was first detected in South Africa and includes the amino acid substitutions D80A, D215G, K417N, E484K, N501Y and A701V relative to the prototypic Wuhan-Hu-1 strain.
SARS-CoV-2 NSP10/NSP16 Methyltransferase, Active
SARS-CoV-2 NSP10/NSP16 methyltransferase is an active recombinant protein expressed in E. coli using a C-terminal His tag. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Powered by Bioz